Drug Patents owned by Santen
1. Drug name - VERKAZIA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9956289 | SANTEN | Emulsion compositions containing quaternary ammonium compounds |
Jan, 2026
(3 years from now) | |
| US9220694 | SANTEN | Emulsion compositions containing cetalkonium chloride |
Jan, 2026
(3 years from now) | |
| US7973081 | SANTEN | Emulsion compositions containing quaternary ammonium compounds |
Jan, 2026
(3 years from now) | |
| US8524779 | SANTEN | Emulsion compositions containing quaternary ammonium compounds |
Jan, 2026
(3 years from now) | |
| US8298568 | SANTEN | Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential |
Nov, 2027
(5 years from now) | |
| US9132071 | SANTEN | Compositions containing quaternary ammonium compounds |
Jun, 2029
(6 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.1% | EMULSION;OPHTHALMIC | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.